16: One of the most-anticipated FDA decisions of the first half of 2024 came early as the regulator approved Vertex Pharmaceuticals and CRISPR Therapeutics Casgevy (exagamglogene autotemcel) as a one-time treatment for transfusion-dependent beta-thalassemia (TDT)
Kaylee Stutts, 30, who switched to compounded semaglutide after running into availability issues with Wegovy Last week, the company reported that second-quarter sales of Ozempic rose 30% to $4.26 billion, while Wegovy sales surged 53% to $1.71 billion
Grande I, Berk M, Birmaher B, Vieta E
Dysbiosis of the gut microbiota may alter host metabolic and signaling pathways, as well as intestinal barrier processes, all of which are either directly or indirectly linked to T2D's insulin resistance (Sharma & Tripathi, 2019)
This concept is borrowed from a lot of different industries, including medicine and skincare, and now factors into pre-liposuction fat loss